Comprehensive mapping of immune perturbations associated with severe COVID-19.
Leticia Kuri-CervantesMaria Betina PampenaWenzhao MengAaron M RosenfeldCaroline A G IttnerAriel R WeismanRoseline S AgyekumDivij MathewAmy E BaxterLaura A VellaOliva KuthuruSokratis A ApostolidisLuanne BershawJeanette DoughertyAllison R GreenplateAjinkya PattekarJustin Y KimNicholas A HanSigrid GoumaMadison E WeirickClaudia P ArevaloMarcus J BoltonEileen C GoodwinElizabeth M AndersonScott E HensleyTiffanie K JonesNilam S MangalmurtiEline T Luning PrakE John WherryNuala J MeyerMichael R BettsPublished in: Science immunology (2020)
Although critical illness has been associated with SARS-CoV-2-induced hyperinflammation, the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively analyzed peripheral blood immune perturbations in 42 SARS-CoV-2 infected and recovered individuals. We identified extensive induction and activation of multiple immune lineages, including T cell activation, oligoclonal plasmablast expansion, and Fc and trafficking receptor modulation on innate lymphocytes and granulocytes, that distinguished severe COVID-19 cases from healthy donors or SARS-CoV-2-recovered or moderate severity patients. We found the neutrophil to lymphocyte ratio to be a prognostic biomarker of disease severity and organ failure. Our findings demonstrate broad innate and adaptive leukocyte perturbations that distinguish dysregulated host responses in severe SARS-CoV-2 infection and warrant therapeutic investigation.
Keyphrases